Huizi-Rayo, Uxua https://orcid.org/0000-0002-2162-9516
Zabala-Lekuona, Andoni https://orcid.org/0000-0002-4666-991X
Terenzi, Alessio https://orcid.org/0000-0001-9751-1373
Cruz, Carlos M. https://orcid.org/0000-0002-0676-5210
Cuerva, Juan M. https://orcid.org/0000-0001-6896-9617
Rodríguez-Diéguez, Antonio https://orcid.org/0000-0003-3198-5378
García, Jose Angel
Seco, José M. https://orcid.org/0000-0002-5131-6764
San Sebastian, Eider https://orcid.org/0000-0001-9263-9626
Cepeda, Javier https://orcid.org/0000-0002-0147-1360
Funding for this research was provided by:
Ministerio de Ciencia, Innovación y Universidades (PGC2018-102052-A-C22, PGC2018-102052-B-C21, FPI contract)
Ekonomiaren Garapen eta Lehiakortasun Saila, Eusko Jaurlaritza (IT1005-16, Predoctoral fellowship)
Centro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológic (FQM-394)
Euskal Herriko Unibertsitatea (GIU 17/13)
European Regional Development Fund
European Social Fund
RELATED DATA
IDENTIFIERS
: Andoni Zabala-Lekuona (ORCID)
: Alessio Terenzi (ResearcherID)
: Carlos M. Cruz (ResearcherID)
: Antonio Rodríguez-Diéguez (ORCID)
PEER REVIEW METHOD
: Single-blind
PUBLICATION HISTORY
: Received 12 February 2020; Accepted 3 May 2020; Accepted Manuscript published 4 May 2020; Advance Article published 27 May 2020; Version of Record published 25 June 2020